Dear JDD readers and colleagues,
The global COVID-19 pandemic has greatly impacted our lives: how we gather and connect has changed to ensure the health and safety of our communities.
During this time, as researchers, health professionals, and scientists around the world collaborate to develop solutions to protect our global community, the JDD has committed to continuing to publish the latest research, updates, and information to help providers better serve patients.
To support community collaboration, the JDD has premiered an online blog where registered users may comment and connect with other dermatology professionals to share information and learn: www.jddonline.com/jdd-blog.
Additionally, stay up-to-date with the latest developments by following JDD on Facebook, Instagram, Twitter, and LinkedIn.
The JDD is committed to providing timely information pertaining to new methods, techniques, drug therapies and devices to our dedicated community of healthcare professionals.
We thank you for your continued support, and wish you all well.
Stay Connected
You May Also Like
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training
Lab to Label training boosts dermatology resident confidence in OTC product counseling Have you read this article from the upcoming April issue of JDD? An IRB approved study assessed topical…
Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security
Enhancing Patient Privacy in Dermatology: Best Practices for Image Organization and Security
Practical imaging security for dermatologists: encryption, secure storage, metadata hygiene and device protocols In this Letter to the Editor published in the February issue of the Journal of Drugs in…
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
